Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

Description

Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the pterygopalatine fossa using a suprazygomatic approach during septorhinoplasty surgery. It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.

Conditions

Deviated Nasal Septum

Study Overview

Study Details

Study overview

Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the pterygopalatine fossa using a suprazygomatic approach during septorhinoplasty surgery. It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.

Post-operative Pain Control With Sphenopalantine Ganglion Nerve Block in Septorhinoplasty Patients

Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

Condition
Deviated Nasal Septum
Intervention / Treatment

-

Contacts and Locations

Gainesville

UF Health of University of Florida, Gainesville, Florida, United States, 32610

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient presenting for open or endoscopic septorhinoplasty
  • * Age 18-80
  • * Normal oral food and water intake before surgery
  • * ASA physical classification 1-3
  • * Refusal to consent
  • * Patients without a cellular phone or who are unable to accept text messages
  • * Allergy to opioid narcotics
  • * ASA physical classification of 4 or higher
  • * Patient requires other surgery in addition to septorhinoplasty
  • * Age \> 80 or \<18
  • * Any underlying chronic pain condition or ongoing opioid use over the preceding 3 months
  • * Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for block placement.
  • * Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for research participation.
  • * Pregnant women

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Florida,

Jeffrey D Johnson, MD, PRINCIPAL_INVESTIGATOR, University of Florida

Study Record Dates

2025-12